Skip to main content

Table 1 Patient characteristics (N = 53)

From: A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma

Characteristics No.of patients (%)
Age (years)
 Median 59
 Range 42-73
Gender
 Male 46 (87.8)
 Female 7 (13.2)
Histology
 Squamous 50 (94.3)
 Adenocarcinoma 3 (5.7)
Tumor location of newly diagnosed 33 (62.2)
 Cervical 2 (3.8)
 Upper thoracic 7 (13.2)
 Middle thoracic 9 (17.0)
 Lower thoracic 9 (17.0)
 Synchronous multiple primary 6 (11.3)
ECOG a score
 0-1 48 (90.6)
 2 5 (9.4)
Stage (UICC b 6 th edition)
 Newly diagnosed 33 (62.2)
 T4NxM0 9 (17.0)
 T2-3NxM0-1 17 (32.0)
 T4NxM1 7 (13.2)
 Postoperative LNMc 20 (37.7)
Planned dose of radiation
 61.2 Gy 41 (77.4)
 50.4 Gy 12 (22.6)
  1. aEastern Cooperative Oncology Group; bUnion for International Cancer Control; Clymph node metastasis